Heart Failure Clinical Trial 2018-038WIRB

[LCID Study Number: 2018-038WIRB]

Autonomic Regulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure With Reduced Ejection Fraction (ANTHEM-HFrEF)

The purpose of this study is to evaluate autonomic regulation therapy to enhance heart function and reduce progression of heart failure.

Disease/Condition: Heart Failure

Department: Cardiology – Anticoagulation

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-1901

View NCT ID 03425422 on ClinicalTrials.gov
Protocol #: 2018-038WIRB
Principal Investigator(s): Richard D. Patten
Study Coordinator(s): Jean Byrne
Trial Phase: Sponsor Initiated Study Category B Device